These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 13682637)

  • 1. Studies on sulfation factor (SF) activity of human serum. The effects of oestrogen and x-ray therapy on serum SF activity in acromegaly.
    ALMQVIST S; IKKOS D; LUFT R
    Acta Endocrinol (Copenh); 1961 May; 37():138-47. PubMed ID: 13682637
    [No Abstract]   [Full Text] [Related]  

  • 2. Studies on sulfation factor (SF) activity of human serum. Serum SF in hypopituitarism and acromegaly.
    ALMQVIST S; IKKOS D; LUFT R
    Acta Endocrinol (Copenh); 1961 Apr; 36():577-95. PubMed ID: 13682635
    [No Abstract]   [Full Text] [Related]  

  • 3. Studies on sulfation factor (SF) activity of human serum. Rate of decrease of serum SF after hypophysectomy.
    ALMQVIST S; FALKHEDEN T
    Acta Endocrinol (Copenh); 1961 Jun; 37():315-20. PubMed ID: 13682634
    [No Abstract]   [Full Text] [Related]  

  • 4. Studies on sulfation factor (SF) activity of human serum. Evaluation of an improved method for the in vitro bioassay of SE and the effect of glutamine and human growth hormone in the sytem.
    ALMQVIST S
    Acta Endocrinol (Copenh); 1961 Jan; 36():31-50. PubMed ID: 14448292
    [No Abstract]   [Full Text] [Related]  

  • 5. Studies on sulfation factor (SF) activity of human serum. The variation of serum SF with age.
    ALMQVIST S; RUNE I
    Acta Endocrinol (Copenh); 1961 Apr; 36():566-76. PubMed ID: 13682638
    [No Abstract]   [Full Text] [Related]  

  • 6. Suppression of growth hormone-dependent human serum sulfation factor by estrogen.
    Wiedemann E; Schwartz E
    J Clin Endocrinol Metab; 1972 Jan; 34(1):51-8. PubMed ID: 5008233
    [No Abstract]   [Full Text] [Related]  

  • 7. Regulation of skeletal growth by sulfation factor.
    Daughaday WH
    Adv Intern Med; 1971; 17():237-63. PubMed ID: 4949905
    [No Abstract]   [Full Text] [Related]  

  • 8. Studies on sulfation factor (SF) activity of human serum. Effect of human growth hormone on SF levels in pituitary dwarfism.
    ALMQVIST S
    Acta Endocrinol (Copenh); 1960 Nov; 35():381-96. PubMed ID: 13682639
    [No Abstract]   [Full Text] [Related]  

  • 9. Criteria for cure of acromegaly: a consensus statement.
    Giustina A; Barkan A; Casanueva FF; Cavagnini F; Frohman L; Ho K; Veldhuis J; Wass J; Von Werder K; Melmed S
    J Clin Endocrinol Metab; 2000 Feb; 85(2):526-9. PubMed ID: 10690849
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Indications and results of pituitary radiotherapy after microsurgery in acromegaly. 15 cases].
    Guittard M; Kuttenn F; Valcke JC; Mauvais-Jarvis P
    Presse Med; 1987 Jun; 16(25):1217-21. PubMed ID: 2955371
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of insulin-like growth factor (somatomedin) levels in acromegaly.
    Rieu M
    Horm Res; 1986; 24(2-3):112-5. PubMed ID: 3530936
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of the overall therapy on the state of the cardiovascular system in acromegaly].
    Kiandarian GG
    Zh Eksp Klin Med; 1978; 18(4):92-5. PubMed ID: 706898
    [No Abstract]   [Full Text] [Related]  

  • 13. [Value of the determination of somatomedins in acromegaly].
    Rieu M
    Presse Med; 1983 Sep; 12(31):1909-10. PubMed ID: 6226000
    [No Abstract]   [Full Text] [Related]  

  • 14. X-ray treatment of ankylosing spondylitis.
    HILTON G
    Rheumatism; 1955 Jan; 11(1):10-5. PubMed ID: 13225388
    [No Abstract]   [Full Text] [Related]  

  • 15. Control of diabetes and other features of acromegaly following treatment with estrogens.
    McCULLAGH EP; BECK JC; SCHAFFENBURG CA
    Diabetes; 1955; 4(1):13-23. PubMed ID: 14365546
    [No Abstract]   [Full Text] [Related]  

  • 16. [Treatment of acromegaly by massive doses of androgens and estrogens combined; results of five cases].
    SCHERMANN J; ESCOSTEGUY JA
    Hospital (Rio J); 1951 Oct; 40(4):533-8. PubMed ID: 14917357
    [No Abstract]   [Full Text] [Related]  

  • 17. [Elevated doses of combines androgens and estrogens in the treatment of acromegaly; results obtained in five cases].
    SCHERMANN J; ESCOSTEGUY JA
    Acta Endocrinol Iber; 1951; 1(3):156-63. PubMed ID: 14932726
    [No Abstract]   [Full Text] [Related]  

  • 18. Pseudohypopituitary dwarfism with normal plasma growth hormone and low serum sulfation factor.
    New MI; Schwartz E; Parks GA; Landey S; Wiedemann E
    J Pediatr; 1972 Apr; 80(4):620-6. PubMed ID: 5015070
    [No Abstract]   [Full Text] [Related]  

  • 19. Brain growth-promoting activity in human serum: relationship to growth hormone and somatomedin.
    Sara VR; Stuart MC; Rutherford R; Moore S; Lazarus L
    J Clin Endocrinol Metab; 1978 Nov; 47(5):1129-31. PubMed ID: 263343
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The relationship between 24-hour growth hormone secretion and insulin-like growth factor I in patients with successfully treated acromegaly: impact of surgery or radiotherapy.
    Peacey SR; Toogood AA; Veldhuis JD; Thorner MO; Shalet SM
    J Clin Endocrinol Metab; 2001 Jan; 86(1):259-66. PubMed ID: 11232010
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.